FDA advisers recommend authorization of Novavax’s Covid-19 vaccine

Experts who advise the Food and Drug Administration voted overwhelmingly on Tuesday to recommend the agency issue an emergency use authorization for Novavax’s Covid-19 vaccine.

Experts who advise the Food and Drug Administration voted overwhelmingly on Tuesday to recommend the agency issue an emergency use authorization for Novavax’s Covid-19 vaccine — a long-awaited win for a company that has struggled to get to this point.

The Vaccines and Related Biological Products Advisory Committee voted 21 to 0 to recommend that the vaccine receive an EUA, with a single abstention. The strong vote belied the tenor of much of the day’s discussion, which started with one member of the committee, Eric Rubin, editor of the New England Journal of Medicine, questioning whether additional EUAs are needed when three vaccines are already in use in the country.

Read the rest…